KeyBanc starts NeuroPace coverage with Overweight rating, $18 target
KeyBanc initiated coverage of NeuroPace with an Overweight rating and a $18.00 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.